hydroxyurea and 2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide

hydroxyurea has been researched along with 2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, X; Ganta, M; Grzeschik, SM; Wang, CH; Xu, C1
Almeida, CB; Conran, N; Costa, FF; Costa, FT; Covas, DT; Leonardo, FC; Souza, LE; Werneck, CC1

Other Studies

2 other study(ies) available for hydroxyurea and 2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide

ArticleYear
Hydroxyurea enhances SMN2 gene expression through nitric oxide release.
    Neurogenetics, 2011, Volume: 12, Issue:1

    Topics: Base Sequence; Cell Line; Cyclic N-Oxides; DNA Primers; Free Radical Scavengers; Gene Expression; Humans; Hydroxyurea; Imidazoles; Lymphocytes; Muscular Atrophy, Spinal; Nitric Oxide; Nitric Oxide Donors; Nitroso Compounds; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Survival of Motor Neuron 2 Protein

2011
Acute hemolytic vascular inflammatory processes are prevented by nitric oxide replacement or a single dose of hydroxyurea.
    Blood, 2015, Aug-06, Volume: 126, Issue:6

    Topics: Anemia, Sickle Cell; Animals; Cell Movement; Cyclic N-Oxides; Disease Models, Animal; Free Radical Scavengers; Hemoglobins; Hemolysis; Humans; Hydrazines; Hydroxyurea; Imidazoles; Inflammation; Leukocytes; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nitric Oxide; Nitric Oxide Donors; Primary Cell Culture; Tumor Necrosis Factor-alpha; Viscosity; Water

2015